155 related articles for article (PubMed ID: 30262596)
1. Differential Effects of Integrin
Stojanović N; Dekanić A; Paradžik M; Majhen D; Ferenčak K; Ruščić J; Bardak I; Supina C; Tomicic MT; Christmann M; Osmak M; Ambriović-Ristov A
Mol Pharmacol; 2018 Dec; 94(6):1334-1351. PubMed ID: 30262596
[TBL] [Abstract][Full Text] [Related]
2. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
3. KANK2 Links αVβ5 Focal Adhesions to Microtubules and Regulates Sensitivity to Microtubule Poisons and Cell Migration.
Paradžik M; Humphries JD; Stojanović N; Nestić D; Majhen D; Dekanić A; Samaržija I; Sedda D; Weber I; Humphries MJ; Ambriović-Ristov A
Front Cell Dev Biol; 2020; 8():125. PubMed ID: 32195252
[TBL] [Abstract][Full Text] [Related]
4. Talin2 and KANK2 functionally interact to regulate microtubule dynamics, paclitaxel sensitivity and cell migration in the MDA-MB-435S melanoma cell line.
Lončarić M; Stojanović N; Rac-Justament A; Coopmans K; Majhen D; Humphries JD; Humphries MJ; Ambriović-Ristov A
Cell Mol Biol Lett; 2023 Jul; 28(1):56. PubMed ID: 37460977
[TBL] [Abstract][Full Text] [Related]
5. In vitro study of combined cilengitide and radiation treatment in breast cancer cell lines.
Lautenschlaeger T; Perry J; Peereboom D; Li B; Ibrahim A; Huebner A; Meng W; White J; Chakravarti A
Radiat Oncol; 2013 Oct; 8():246. PubMed ID: 24153102
[TBL] [Abstract][Full Text] [Related]
6. The integrin antagonist cilengitide increases the antitumor activity of temozolomide against malignant melanoma.
Tentori L; Dorio AS; Muzi A; Lacal PM; Ruffini F; Navarra P; Graziani G
Oncol Rep; 2008 Apr; 19(4):1039-43. PubMed ID: 18357394
[TBL] [Abstract][Full Text] [Related]
7. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.
Ahmed N; Riley C; Rice G; Quinn M
Clin Exp Metastasis; 2005; 22(5):391-402. PubMed ID: 16283482
[TBL] [Abstract][Full Text] [Related]
8. αv-Integrin isoform expression in primary human tumors and brain metastases.
Vogetseder A; Thies S; Ingold B; Roth P; Weller M; Schraml P; Goodman SL; Moch H
Int J Cancer; 2013 Nov; 133(10):2362-71. PubMed ID: 23661241
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of six aspartate (D) recombinant mojastin mutants (r-Moj): A second aspartate amino acid carboxyl to the RGD in r-Moj-D_ peptides is not sufficient to induce apoptosis of SK-Mel-28 cells.
Ramos CJ; Gutierrez DA; Aranda AS; Koshlaychuk MA; Carrillo DA; Medrano R; McBride TD; U A; Medina SM; Lombardo MC; Lucena SE; Sanchez EE; Soto JG
Toxicon; 2016 Aug; 118():36-42. PubMed ID: 27105671
[TBL] [Abstract][Full Text] [Related]
10. Effects of cilengitide in osteoclast maturation and behavior.
Chillà A; Bianconi D; Geetha N; Dorda A; Poettler M; Unseld M; Sykoutri D; Redlich K; Zielinski CC; Prager GW
Exp Cell Res; 2015 Sep; 337(1):68-75. PubMed ID: 26209605
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome Profile Analysis of Triple-Negative Breast Cancer Cells in Response to a Novel Cytostatic Tetrahydroisoquinoline Compared to Paclitaxel.
Gangapuram M; Mazzio EA; Redda KK; Soliman KFA
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299315
[TBL] [Abstract][Full Text] [Related]
12. LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP.
Lai H; Wang R; Li S; Shi Q; Cai Z; Li Y; Liu Y
Sci China Life Sci; 2020 Mar; 63(3):419-428. PubMed ID: 31420851
[TBL] [Abstract][Full Text] [Related]
13. 1-Chromonyl-5-Imidazolylpentadienone Demonstrates Anti-Cancer Action against TNBC and Exhibits Synergism with Paclitaxel.
Modi K; Lawson S; Chen G; Tumuluri D; Rekhtman I; Kurtz M; Brailoiu GC; Chen QH; Lakshmikuttyamma A
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806551
[TBL] [Abstract][Full Text] [Related]
14. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.
Blanchard Z; Paul BT; Craft B; ElShamy WM
Breast Cancer Res; 2015 Jan; 17(1):5. PubMed ID: 25583261
[TBL] [Abstract][Full Text] [Related]
15. αvβ1 integrin is enriched in extracellular vesicles of metastatic breast cancer cells: A mechanism mediated by galectin-3.
Zhang DX; Dang XTT; Vu LT; Lim CMH; Yeo EYM; Lam BWS; Leong SM; Omar N; Putti TC; Yeh YC; Ma V; Luo JY; Cho WC; Chen G; Lee VKM; Grimson A; Le MTN
J Extracell Vesicles; 2022 Aug; 11(8):e12234. PubMed ID: 35923105
[TBL] [Abstract][Full Text] [Related]
16. Integrin chains beta1 and alphav as prognostic factors in human metastatic melanoma.
Nikkola J; Vihinen P; Vlaykova T; Hahka-Kemppinen M; Heino J; Pyrhönen S
Melanoma Res; 2004 Feb; 14(1):29-37. PubMed ID: 15091191
[TBL] [Abstract][Full Text] [Related]
17. The Na⁺/H⁺ exchanger (NHE1) as a novel co-adjuvant target in paclitaxel therapy of triple-negative breast cancer cells.
Amith SR; Wilkinson JM; Baksh S; Fliegel L
Oncotarget; 2015 Jan; 6(2):1262-75. PubMed ID: 25514463
[TBL] [Abstract][Full Text] [Related]
18. miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells.
Das SG; Romagnoli M; Mineva ND; Barillé-Nion S; Jézéquel P; Campone M; Sonenshein GE
Breast Cancer Res; 2016 Apr; 18(1):40. PubMed ID: 27039296
[TBL] [Abstract][Full Text] [Related]
19. Cilengitide, an αvβ3-integrin inhibitor, enhances the efficacy of anti-programmed cell death-1 therapy in a murine melanoma model.
Pan X; Yi M; Liu C; Jin Y; Liu B; Hu G; Yuan X
Bioengineered; 2022 Feb; 13(2):4557-4572. PubMed ID: 35142593
[TBL] [Abstract][Full Text] [Related]
20. SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer.
Liu XY; Jiang W; Ma D; Ge LP; Yang YS; Gou ZC; Xu XE; Shao ZM; Jiang YZ
Theranostics; 2020; 10(24):10940-10956. PubMed ID: 33042263
[No Abstract] [Full Text] [Related]
[Next] [New Search]
